Journal profile · Pathology
Advances in Anatomic Pathology
ISSN 1072-4109 · eISSN 1533-4031 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1994
Advances in Anatomic Pathology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 2.78; JCR Q2 (journal website); hybrid open access; median 95 days to acceptance (32 articles, last 24 months); community-reported acceptance: moderate; 36 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Advances in Anatomic Pathology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment and Soft tissue tumor case studies, together about 22.7% of its articles. Its main subfields are Pathology and Forensic Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Advances in Anatomic Pathology provides targeted coverage of the key developments in anatomic and surgical pathology. It covers subjects ranging from basic morphology to the most advanced molecular biology techniques. The journal selects and efficiently communicates the most important information from recent world literature and offers invaluable assistance in managing the increasing flow of information in pathology.
Source: LetPub
Research area (LetPub): Pathology
Editor-in-chief Mahul B. AminPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine10.9%
- Lymphoma Diagnosis and TreatmentMedicine6.8%
- Soft tissue tumor case studiesMedicine5%
- Salivary Gland Tumors Diagnosis and TreatmentMedicine4.7%
- Tumors and Oncological CasesMedicine4.6%
- Ovarian cancer diagnosis and treatmentMedicine4.2%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.1%
- Viral-associated cancers and disordersMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · PATHOLOGY · rank 32/89
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.78LetPub ·
- Impact factor (publisher)
- 2.8Publisher website ·
- CiteScore 2026-06
- 5.8LetPub ·
- SJR 2026-06
- 1.03LetPub ·
- SNIP 2026-06
- 1.29LetPub ·
- h-index
- 69LetPub ·
- h-index
- 113OpenAlex ·
- i10-index
- 820OpenAlex ·
- 2-year mean citedness
- 2.58OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 5.69%LetPub ·
Volume
- Articles per year
- 34LetPub ·
Articles by year OpenAlex count · 2,724 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 4 | 9 |
| 2025 | 36 | 2 | 80 |
| 2024 | 54 | 3 | 234 |
| 2023 | 34 | 6 | 271 |
| 2022 | 61 | 5 | 688 |
| 2021 | 40 | 5 | 1,277 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
95 daysMedian, submission to acceptance · P25–P75 64 days – 176 days
- Acceptance to online
- median 25 days (32 articles)
- Submission to online
- median 117 days
- Sample
- 32 articles with submission and acceptance dates (89 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1994
- ISSN
- 1072-4109
- Electronic ISSN
- 1533-4031
- Latest issue on the website
- Volume 33, Issue 5 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Advances in Anatomic Pathology
What CAS zone is Advances in Anatomic Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Advances in Anatomic Pathology is in Zone 2 of Medicine, and in Zone 2 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Advances in Anatomic Pathology?
The latest impact factor listed by LetPub is 2.78; CiteScore 5.8, h-index 113.
How long does peer review take at Advances in Anatomic Pathology?
Based on the dates recorded on 32 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 64–176 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Advances in Anatomic Pathology in?
The journal's website gives JCR Q2; by category, PATHOLOGY Q2 (32/89). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Which databases index Advances in Anatomic Pathology?
According to LetPub and DOAJ records, Advances in Anatomic Pathology is indexed in SCIE and Scopus.
Is Advances in Anatomic Pathology open access, and what is the APC?
Advances in Anatomic Pathology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .